Page 10 - இந்தியன் காப்புரிமை அலுவலகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
NATCO signs Voluntary Licensing Agreement with Lilly for Baricitinib for Covid-19 in India
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Natco Pharma signs pact with Eli Lilly for Baricitinib
Updated:
Updated:
Withdraws application seeking Compulsory License against Lilly for the COVID-19 drug
Share Article
Withdraws application seeking Compulsory License against Lilly for the COVID-19 drug
Natco Pharma has signed a royalty-free, non-exclusive, voluntary licensing agreement with pharma major Eli Lilly for the manufacture and commercialisation of Baricitinib, a drug indicated for the treatment of COVID-19.
In line with the agreement, Natco has withdrawn the application filed with the Indian Patent Office seeking Compulsory License against Lilly for Baricitinib for COVID-19 in India, the company said on Monday.
Earlier this month, Natco had received emergency use authorisation for Baricitinib tablets from the Central Drugs Standard Control Organisation (CDSCO). The drug is for use, in combination with Remdesivir, in treatment of suspected or laboratory confirmed COVID-19 in hospitalised adults requiring suppleme
Panacea Biotec Limited files suit against Sanofi Healthcare India Pvt Ltd
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Covid vaccine patents can be waived without hurting firms like Bharat Biotech. Here’s how © Provided by The Print
With the second wave of the Covid-19 pandemic wreaking havoc on the lives of people across the world, but more so in India, there is a growing urgency to vaccinate the entire population at the earliest. The current challenge lies in the demand-supply mismatch, mainly due to limited production capacity of vaccines. For India to achieve universal vaccination, the requirement is of 1,878 million doses two doses each for 939 million adults. As there are only two manufacturers Bharat Biotech and Serum Institute of India with their current production capacity at 80-90 million doses per month, which could expand to 160 million doses by July 2021, there is a demand-supply gap that needs to be bridged on a war footing.
Patents granted to IIT Indore for inventions
Indore
IIT Indore has been granted 2 patents by Indian Patent Office for its novel inventions. One patent has been secured by Dept of Bioscience and Biomedical Engineering faculty member Prof Avinash Sonawane, and another by Dr Anirban Sengupta of Computer Science Dept.
Sonawane got patent for his novel research on The development of asparaginase drug for the treatment of blood cancer . This a new asparaginase drug (M-ASPAR) using protein engineering approach to treat Acute Lymphocytic LeukeÂmia, a type of blood cancer.
Similarly, Sengupta got patent for invention on Design Space Exploration System and Method thereof using a Bacterial Foraging Optimization Mechanism that is useful for designing digital chips of camera systems and mobile devices. The invention is several magnitudes efficient that other state of the art inventions used for this purpose. The invention is capable to enhance the speed of chips and reduce power using
vimarsana © 2020. All Rights Reserved.